Secukinumab in the Treatment of Noninfectious Uveitis: Results of Three Randomized, Controlled Clinical Trials

Date
2013
Author
LIEW, S. H. Melissa
Tugal-Tutkun, Ilknur
ZIERHUT, Manfred
BEZLYAK, Vladimir
Androudi, Sofia
Dick, Andrew D.
Foster, Stephen
Metadata
Show full item record
Abstract
Purpose: To determine the efficacy and safety of different doses of secukinumab, a fully human monoclonal antibody for targeted interleukin-17A blockade, in patients with noninfectious uveitis.
URI
http://hdl.handle.net/20.500.12627/23592
https://doi.org/10.1016/j.ophtha.2012.09.040
Collections